136 related articles for article (PubMed ID: 25563222)
1. Personalized Medicine's Bottleneck: Diagnostic Test Evidence and Reimbursement.
Cohen JP; Felix AE
J Pers Med; 2014 Apr; 4(2):163-75. PubMed ID: 25563222
[TBL] [Abstract][Full Text] [Related]
2. Clinical and economic challenges facing pharmacogenomics.
Cohen J; Wilson A; Manzolillo K
Pharmacogenomics J; 2013 Aug; 13(4):378-88. PubMed ID: 22231566
[TBL] [Abstract][Full Text] [Related]
3. Comparing patient access to pharmaceuticals in the UK and US.
Cohen J; Cairns C; Paquette C; Faden L
Appl Health Econ Health Policy; 2006; 5(3):177-87. PubMed ID: 17132032
[TBL] [Abstract][Full Text] [Related]
4. A review of international coverage and pricing strategies for personalized medicine and orphan drugs.
Degtiar I
Health Policy; 2017 Dec; 121(12):1240-1248. PubMed ID: 29033060
[TBL] [Abstract][Full Text] [Related]
5. Overcoming regulatory and economic challenges facing pharmacogenomics.
Cohen JP
N Biotechnol; 2012 Sep; 29(6):751-6. PubMed ID: 22370122
[TBL] [Abstract][Full Text] [Related]
6. Reimbursement and coverage challenges associated with bringing emerging molecular diagnostics into the personalized medicine paradigm.
Ridge JR
Per Med; 2006 Aug; 3(3):345-348. PubMed ID: 29788649
[TBL] [Abstract][Full Text] [Related]
7. Payers and the assessment of clinical utility for companion diagnostics.
Quinn B
Clin Pharmacol Ther; 2010 Dec; 88(6):751-4. PubMed ID: 21081944
[TBL] [Abstract][Full Text] [Related]
8. Drug pricing and value in oncology.
Danzon PM; Taylor E
Oncologist; 2010; 15 Suppl 1():24-31. PubMed ID: 20237214
[TBL] [Abstract][Full Text] [Related]
9. Off-label use reimbursement.
Cohen J; Wilson A; Faden L
Food Drug Law J; 2009; 64(2):391-403. PubMed ID: 19999289
[TBL] [Abstract][Full Text] [Related]
10. [Current situation and challenges in companion diagnostics development].
Nishida M
Gan To Kagaku Ryoho; 2014 Dec; 41(13):2529-34. PubMed ID: 25596043
[TBL] [Abstract][Full Text] [Related]
11. Are payers treating orphan drugs differently?
Cohen JP; Felix A
J Mark Access Health Policy; 2014; 2():. PubMed ID: 27226840
[TBL] [Abstract][Full Text] [Related]
12. [The current issues on development and clinical use of companion diagnostics and prospects of personalized medicine for the future].
Tazawa Y
Yakugaku Zasshi; 2014; 134(4):491-8. PubMed ID: 24694808
[TBL] [Abstract][Full Text] [Related]
13. The Value of Companion Diagnostics: Overcoming Access Barriers to Transform Personalised Health Care into an Affordable Reality in Europe.
Wurcel V; Perche O; Lesteven D; Williams DA; Schäfer B; Hopley C; Jungwirth R; Postulka A; Pasmans R; Hermansson LL; Ott M; Glorioso V
Public Health Genomics; 2016; 19(3):137-43. PubMed ID: 27237134
[TBL] [Abstract][Full Text] [Related]
14. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
O'Donnell JC
Value Health; 2013; 16(6 Suppl):S1-3. PubMed ID: 24034305
[TBL] [Abstract][Full Text] [Related]
15. A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics.
Luo D; Smith JA; Meadows NA; Schuh A; Manescu KE; Bure K; Davies B; Horne R; Kope M; DiGiusto DL; Brindley DA
Front Genet; 2015; 6():357. PubMed ID: 26858745
[TBL] [Abstract][Full Text] [Related]
16. Current Trends in Personalized Medicine and Companion Diagnostics: A Summary From the DIA Meeting on Personalized Medicine and Companion Diagnostics.
Tsourounis M; Stuart J; Pignato W; Toscani M; Barone J
Ther Innov Regul Sci; 2015 Jul; 49(4):530-543. PubMed ID: 30222427
[TBL] [Abstract][Full Text] [Related]
17. Reflections on market access for personalized medicine: recommendations for Europe.
Payne K; Annemans L
Value Health; 2013; 16(6 Suppl):S32-8. PubMed ID: 24034310
[TBL] [Abstract][Full Text] [Related]
18. The current and future state of companion diagnostics.
Agarwal A; Ressler D; Snyder G
Pharmgenomics Pers Med; 2015; 8():99-110. PubMed ID: 25897259
[TBL] [Abstract][Full Text] [Related]
19. Regulation, reimbursement, and the long road of implementation of personalized medicine--a perspective from the United States.
Frueh FW
Value Health; 2013; 16(6 Suppl):S27-31. PubMed ID: 24034309
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
